No clinical utility of KRAS variant rs61764370 for ovarian or breast cancer. (2016)

First Author: Ovarian Cancer Association Consortium, Breast Cancer Association Consortium, And Consortium Of Modifiers Of BRCA1 And BRCA2
Attributed to:  King's Health Partners Confidence in Concept funded by MRC

Abstract

No abstract provided

Bibliographic Information

Digital Object Identifier: http://dx.doi.org/10.1016/j.ygyno.2015.04.034

PubMed Identifier: 25940428

Publication URI: http://europepmc.org/abstract/MED/25940428

Type: Journal Article/Review

Volume: 141

Parent Publication: Gynecologic oncology

Issue: 2

ISSN: 0090-8258